Financial statements Westpol-Teeuwissen Pharma
Cash flow statement of Westpol-Teeuwissen Pharma
Company age:
Age:
15 y. 10 m. 4 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of WESTPOL-TEEUWISSEN PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | 7 073 196,50 | 12 984 065,06 | 21 567 979,80 | 18 870 289,46 | 5 390 270,26 |
| Net cash flow from investing activities | -352 619,20 | -617 877,54 | -378 088,04 | -565 727,33 | -192 219,48 |
| Net cash flow from financial activities | -1 941 733,58 | -15 194 419,93 | -15 232 956,26 | -3 287 261,64 | -237 879,53 |
| Total net cash flow | 4 778 843,72 | -2 828 232,41 | 5 956 935,50 | 15 017 300,49 | 4 960 171,25 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.